| Hazard Information | Back Directory | [Description]
BDP8900 is a potent and selective MRCK inhibitor, reducing substrate phosphorylation. BDP8900 leads to morphological changes in cancer cells along with inhibition of their motility and invasive character. | [Uses]
BDP8900 is a potent and selective inhibitor of myotonic dystrophy-related Cdc42-binding kinases (MRCKα and MRCKβ). BDP8900 reduces substrate phosphorylation, leading to morphological changes, motility inhibition and invasiveness of cancer cells[1]. | [References]
[1] Discovery of potent and selective MRCK inhibitors with therapeutic effect on skin cancer |
|
|